SCHEMBL14907015

SCHEMBL14907015

O=C(N/N=C/c1cc(Cl)cc(Cl)c1O)c1ccc(O)c(O)c1O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 2/20 0.72
KDM4E B2RXH2 7/20 0.62
KMT2A Q03164 7/20 0.62
MEN1 O00255 6/20 0.62
TDP1 Q9NUW8 2/20 0.62
NPC1 O15118 2/20 0.62
L3MBTL1 Q9Y468 2/20 0.62
USP2 O75604 1/20 0.62
MCOLN3 Q8TDD5 1/20 0.62
KDM1A O60341 2/20 0.57
MAPT P10636 4/20 0.53
NTRK1 P04629 1/20 0.52
HTT P42858 4/20 0.52
LMNA P02545 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
GCGR P47871 1/20 0.49
ALOX12 P18054 1/20 0.49
RAB9A P51151 3/20 0.48
PSMD14 O00487 1/20 0.48
POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14907018 0.88 PIK3CG (0.63) PIK3CGKDM4EKMT2AMEN1TDP1
SCHEMBL14906948 0.88 KMT2A (0.59) PIK3CGKDM4EKMT2AMEN1TDP1
SCHEMBL685087 0.87 PIK3CG (0.80) PIK3CGKDM4EKMT2AMEN1TDP1
SCHEMBL684820 0.87 PIK3CG (0.69) PIK3CGKDM4EKMT2AMEN1TDP1
SCHEMBL14907007 0.87 PIK3CG (0.58) PIK3CGKDM4EKMT2AMEN1NPC1
SCHEMBL14907019 0.87 PIK3CG (0.71) PIK3CGKDM4EKMT2AMEN1NPC1
SCHEMBL684495 0.87 PIK3CG (0.72) PIK3CGKDM4EKMT2AMEN1TDP1
SCHEMBL14906950 0.86 PIK3CG (0.58) PIK3CGKDM4EKMT2AMEN1TDP1
SCHEMBL1639165 0.85 PIK3CG (0.72) PIK3CGKDM4EKMT2AMEN1TDP1
SCHEMBL1639164 0.85 PIK3CG (0.72) PIK3CGKDM4EKMT2AMEN1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9873661-B2 Small molecule malarial Aldolase-TRAP enhancers and glideosome inhibitors NEW YORK UNIVERSITY (US) 2018-01-23 US disclosed
US-20140275088-A1 SMALL MOLECULE MALARIAL ALDOLASE-TRAP ENHANCERS AND GLIDEOSOME INHIBITORS THE JOHNS HOPKINS UNIVERSITY 2014-09-18 US disclosed
WO-2013063243-A1 SMALL MOLECULE MALARIAL ALDOLASE-TRAP ENHANCERS AND GLIDEOSOME INHIBITORS NEW YORK UNIVERSITY (US) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140275088-A1 SMALL MOLECULE MALARIAL ALDOLASE-TRAP ENHANCERS AND GLIDEOSOME INHIBITORS ALDOA, DERA, TALDO1 PIK3CG 3964/4885KDM4E 283/4885KMT2A 929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.